Johnson & Johnson

Business description

Johnson & Johnson (J&J) is a global healthcare giant operating in Pharmaceuticals and MedTech. It is a leader in a wide array of healthcare categories, including immunology, oncology, and vision care.

Key financials

• **H-Score:**87
• Market Cap: ~USD 581.7B.

Competitive moat

J&J possesses an unparalleled R&D budget and a highly diversified revenue stream. In Vision Care, it is the global leader in the contact lens market and a primary competitor in the intraocular lens (IOL) space.

Recent developments

• Vision Care Competition: J&J's PureSee IOL is projected to pressure [[Alcon AG]]'s US PC-IOL franchise in 2026, highlighting J&J's aggressive innovation in the surgical eye care space.
• Portfolio Pivot: Following the spinoff of its consumer health division (Kenvue), J&J is now a more focused, higher-margin healthcare entity.

Investment risks / red flags

• Litigation: Like all major pharma companies, it faces ongoing legal risks related to product liability.
• Drug Pricing: Exposure to regulatory changes and pricing pressure in the US pharmaceutical market.

H-Score signals

• TBI multi factor score: 87

Theme exposure

• [[Healthcare Innovation]] (Pending page)
• [[Demographic Shifts]] (Pending page)

Related: [[Healthcare]] [[Comparison: Vision Care]]